Latest Asx News

InhaleRx Limited has secured key ethics approvals and initiated manufacturing for its inhaled drug candidates targeting breakthrough cancer pain and panic disorder, supported by a $38.5 million funding facility to accelerate development.

Dollarama Inc. has officially acquired The Reject Shop, paying shareholders $5.91 per share and triggering the retailer's imminent delisting from the ASX.

Alternative Investment Trust (ASX, AIQ) announces a special unfranked distribution of AUD 0.04647 per unit, representing a full return of capital payable in early August.

ECP Emerging Growth Limited reports steady financial health for its convertible notes, confirming a stable loan-to-value ratio and full compliance with regulatory requirements for Q2 2025.

Global Masters Fund Limited has released its quarterly update confirming stable convertible note conversions and a low loan-to-value ratio, underscoring its solid financial footing as of June 2025.

Flagship Investments Limited has reported steady financial health in its latest quarterly filing, confirming a stable loan-to-value ratio and full compliance with convertible note obligations for Q2 2025.

Macarthur Minerals has extended the timetable for its A$2 million renounceable rights issue, providing shareholders additional time to participate amid ongoing regulatory scrutiny by ASIC. The company confirms no changes to the offer terms and expects to lodge an updated Supplementary Prospectus shortly.

WAM Global Limited outperformed the MSCI World Index with a 19.4% portfolio gain in FY2025, prompting an increased fully franked dividend of 17.0 cents per share. The company’s strong results reflect strategic positioning amid global market volatility.

Theta Gold Mines Limited has provided a comprehensive update on its Transvaal Gold Mining Estates project, targeting first gold production by early 2027 with a robust feasibility study and secured cornerstone funding.

Beacon Minerals has initiated its largest reverse circulation drilling campaign at the Lady Ida Iguana Deposit, aiming to enhance geological confidence and update mineral resources by mid-2026.

Streamplay Studio Limited has posted a positive operating cash flow for the first time since its acquisition-led growth strategy began, buoyed by strong game launches and a new multi-year licensing agreement with Amazon.

Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.